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A soluble single-point mutant of full-length Mos1 mariner transpos-
ase (MW = 40.7 kDa) has been overexpressed in Escherichia coli,
puri®ed to 95% homogeneity and crystallized. This provides the ®rst
example of the crystallization of a eukaryotic transposase. The native
crystals diffract to 2.5 AÊ resolution and show tetragonal symmetry,
with unit-cell parameters a = b = 44.5, c = 205.6 AÊ . Multiple-
wavelength anomalous data from a selenomethionyl form of the
protein and data from a heavy-atom derivative have been collected.
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1. Introduction
The mariner element Mos1 (®rst isolated from
Drosophila mauritiana) is a member of the
mariner/Tc1 superfamily of transposable
elements (Robertson, 1995). It encodes a
40.7 kDa transposase (containing 345 residues
in the sequence shown in Fig. 1) that is the sole
requirement for transposition of the element in
vitro. This enzyme catalyses a set of DNA-
cleavage and DNA-insertion reactions in a cut-
and-paste mechanism. In the ®rst step of this
reaction, the transposase speci®cally recog-
nizes and binds to the terminal inverted
repeats of its own transposon via its N-terminal
domain formed of the ®rst 118 amino acids
(Zhang et al., 2001). The catalytic C-terminal
domain mediates the subsequent excision of
the transposon from the ¯anking DNA and its
insertion into a target sequence. After disen-
gagement of the protein from the DNA, the
5 bp single-strand gaps at each end are
repaired. Mos1 transposase contains a variant,
DD(34)D, of the catalytic DD(35)E motif (van
Luenen et al., 1994) that is required for di-
valent metal (Mg2+) binding and is conserved
among polynucleotide phosphotransferases.
These include integrases, which are encoded by
retroviruses and retrotransposons, and trans-
posases of the bacterial elements Tn5 and Tn10
and other members of the mariner/Tc1 family.
The mechanism of transposition has been
studied in detail for a number of prokaryotic
elements, including Tn5 (Reznikoff, 2003) and
Tn10 (Kennedy et al., 1998). The crystal
structure of Tn5 transposase in a synaptic
complex provided the ®rst structural insight
into a transposase in its active DNA-bound
state (Davies et al., 2000). Other studies have
revealed the structures of domains of bacterial
transposases (Rice & Mizuuchi, 1995; Schu-
macher et al., 1997) and related integrases
(Chen et al., 2000; Wang et al., 2001). In
contrast, less is known about the detailed
mechanisms of eukaryotic transposition or the
structures of the transposases involved. A
recent biochemical analysis of the excision of
DNA by Mos1 transposase (Dawson &
Figure 1
Sequence of Mos1 transposase. The N-terminal domain (residues 1±118) is coloured red and the C-terminal domain
(residues 119±345) is coloured blue. An orange circle highlights the position of the single mutation T216A. Purple stars
indicate the three active-site aspartic acid residues. Methionine residues are coloured green. The secondary structure
predicted by the PredictProtein server is also shown. This diagram was created using the program ESPript.
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Finnegan, 2003) highlighted differences in
the mechanism of DNA cleavage by the
enzyme compared with that by prokaryotic
transposases. Moreover, similarities were
found with the RAG1/2-mediated assembly
of immunoglobulin and T-cell receptor
genes in V(D)J recombination, consistent
with the proposal that the modern immune
system has evolved from a transposon more
like Mos1 than bacterial transposons such as
Tn5.
Structural analysis of Mos1 transposase
has been precluded for many years owing to
the insoluble nature of the protein when
expressed in Escherichia coli. Here, we
report the cloning, overexpression, puri®ca-
tion and crystallization of a soluble
single-point mutant of full-length Mos1
transposase.
2. Materials and methods
2.1. Protein cloning and overexpression
The single-point mutation (T216A) was
isolated in a yeast two-hybrid screen
designed to identify transposase derivatives
that are able to interact more strongly with
the wild-type protein. The sequence coding
for the mutant protein was ampli®ed by
PCR and inserted into the E. coli expression
vector pBCP378 (Velterop et al., 1995) using
NdeI and BamHI restriction sites in the PCR
primers. DNA sequencing con®rmed the
integrity of the cloned fragment. The
recombinant plasmid was transformed into
strain BL21(DE3) (Novagen) and plated
out on LB agar containing carbenicillin
(200 mg mlÿ1). Single colonies were used to
inoculate 50 ml of LB medium with carbe-
nicillin. After overnight incubation at 303 K,
these cultures were diluted into 500 ml LB
medium (with 200 mg mlÿ1 carbenicillin).
Expression of the transposase was induced
by the addition of isopropyl--d-thio-
galactopyranoside (IPTG) when the cell
culture grown at 310 K had attained late log
phase (OD600 = 0.6). The mutant protein was
shown by SDS±PAGE to be present in the
soluble fraction of the total cell lysate.
Expression conditions were optimized and
the best level of expression was achieved
using 1.0 mM IPTG for 4 h at 303 K.
For the production of selenomethionyl
protein, the expression construct was trans-
formed into the methionine-de®cient E. coli
strain B834(DE3). Single colonies grown on
agar plates (with 200 mg mlÿ1 carbenicillin)
were used to inoculate 50 ml overnight
cultures of LB medium. These were pelleted
and used to inoculate (to OD600 = 0.2) a
minimal medium containing selenomethio-
nine, along with the other 19 amino acids,
and protein production was induced with
IPTG as before. The subsequent extraction
and puri®cation of selenomethionyl protein
proceeded as described below apart from
the incorporation of 5 mM DTT in all
buffers.
2.2. Protein purification and analysis
Cells collected from 1 l cell culture by
centrifugation (2500g for 20 min at 277 K)
were frozen overnight and then suspended
in 20 ml extraction buffer (buffer A; 25 mM
NaH2PO4, 500 mM NaCl, 5 mM MgCl2,
1 mM DTT pH 7.5) containing Complete
protease-inhibitor mix (Roche). Lysozyme
(100 ml at 100 mg mlÿ1 in buffer A) was
added and the mixture was incubated on ice
for 15 min and then sonicated. DNaseI
(200 U, Sigma) was added and the suspen-
sion was incubated on ice for a further
30 min. The cell lysate was centrifuged at
2500g for 30 min at 277 K and the precipi-
tate was discarded. Initially, the crude
extract was applied onto a Poros HS cation-
exchange column on a BioCAD Sprint
FPLC system (Applied Biosystems) and
eluted with a salt gradient (0.2±1 M NaCl).
Fractions eluting at approximately 0.6 M
NaCl were shown by SDS±PAGE to contain
Mos1 transposase. These fractions were
pooled, concentrated and exchanged into
buffer B (25 mM Tris, 0.2 M NaCl, 1 mM
DTT pH 7.5) in a Vivaspin 20 ml centrifugal
concentrator with a 10 kDa cutoff. Subse-
quently, the protein was passed through a
Superdex 200 HR10/30 gel-®ltration column
on an AKTA FPLC system (Amersham
Pharmacia Biotech) in buffer B at
0.2 ml minÿ1. In this way Mos1 transposase
was puri®ed to 95% homogeneity, as
con®rmed by SDS±PAGE, with a typical
yield of 3 mg per litre of LB medium.
The mutant protein was shown in trans-
position assays and gel-retardation experi-
ments to have identical activity to wild-type
protein (Dawson & Zhang, personal
communication). The molecular weight of
puri®ed transposase was found to be
40 662 Da by MALDI±TOF mass spectro-
metry, compared with the predicted weight
of 40 665 Da taking into account the loss of
the ®rst methionine residue. The molecular
weight of the selenomethionine-substituted
protein was 40 925 Da. The difference in
weight of 259 Da indicated 100% incor-
poration of ®ve Se atoms (47 Da difference
per selenium) plus one Mg atom (24 Da).
2.3. Protein crystallization and preparation
of heavy-atom derivatives
The hanging-drop vapour-diffusion
method was used to grow crystals in 24-well
Limbro plates. Plate-like crystals (shown in
Fig. 2) with dimensions of up to 0.1  0.1 
0.02 mm grew after three weeks at 290 K
under the following conditions: the well
solution consisted of 22±26%(w/v) PEG
4000, 0.1 M Tris buffer pH 7.5 and 5 mM
MgCl2 and the drop consisted of 2 ml protein
solution at 13 mg mlÿ1 in buffer B plus
2 ml well solution. Selenomethionine-protein
crystals were obtained by streak-seeding
with a cat's whisker from a drop containing a
crushed native crystal. A mercury derivative
was obtained by soaking native crystals for
10 min in well solution containing 10 mM
KHgI3 followed by back-soaking into well
solution. Prior to data collection, all crystals
were brie¯y immersed in a cryoprotectant
solution comprising 20%(v/v) glycerol in
mother liquor and ¯ash-cooled by plunging
into liquid nitrogen. All diffraction data
were collected at 100 K.
2.4. Biochemical analysis of the crystals
Native crystals were extracted from the
hanging drops and washed in water before
being dissolved in a 1:1 water:acetonitrile
solution for N-terminal sequence analysis or
2%(w/v) SDS for analysis by PAGE and
mass spectrometry. N-terminal sequence
analysis of the native crystal (Procise
sequencer, Applied Biosystems) predicted
a sequence containing the residues
(F/W)VPN. This could correspond to resi-
dues 4±7 with sequence FVPN and/or to
residues 119±122 with sequence WVPH (see
Fig. 1). MALDI±TOF mass spectrometry
and SDS±PAGE (gel shown in Fig. 3) of the
denatured and solubilized crystals indicated
that the crystals contained or cleaved into
four fragments: fragment A of 27.3 kDa,
fragment B of 19.1 kDa, fragment C of
19.69 kDa and fragment D of 6 kDa.
These fragments are consistent with the
C-terminal domain (fragment A), residues
Trp119±Glu345 (27.1 kDa), fragment B
Ser2±Arg167 (19.72 kDa), fragment C
Figure 2
Crystals of Mos1 transposase.
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Pro184±Glu345 (19.273 kDa) and fragment
D Trp119±Arg183 (7.87 kDa) or Trp119±
Arg 167 (6.186 kDa). The in vitro cleavage
of Mos1 adjacent to Arg119, Arg167 and
Arg183 is consistent with the action of a
protease and may re¯ect a role for protein
degradation in vivo. For Tn5 it has been
suggested that disengagement of the protein
from DNA after transposition may be
facilitated in vivo by proteolytic cleavage at
Lys40 (Twining et al., 2001).
2.5. X-ray data collection
Data were collected at the Daresbury SRS
(station 14.2, various wavelengths) with an
ADSC Q4 CCD detector and at the ESRF,
Grenoble (station ID29, various wave-
lengths) with an ADSC Q210 CCD detector.
In order to achieve the optimal alignment of
the long c axis of the crystal with the spindle
axis, crystals were either mounted in bent
loops or positioned on a swing-arc gonio-
meter head (Hampton Research). For MAD
data, ¯uorescence spectra were measured to
determine the absorption edge of selenium
and data sets were measured at three
wavelengths: the in¯ection point (0.98067 AÊ ,
1) and the peak (0.98017 AÊ , 2) of the edge
plus a low-energy remote wavelength
(1.000 AÊ , 3). The mercury-derivative data
were collected at a wavelength of 1.005 AÊ .
All data were collected using a ’ scan with a
step size of 1.0 and indexing and scaling of
data was performed using DENZO and
SCALEPACK (Otwinowski & Minor,
1997).
3. Results and discussion
3.1. Unit-cell determination
The diffraction data (see Table 1) were
consistent with space group P41212 or
P43212, with unit-cell parameters a = b = 44.5,
c = 205.6 AÊ . In this space group, with one
molecule of intact protein in the asymmetric
unit (eight molecules per unit cell), the value
of VM is 1.3 AÊ
3 Daÿ1 (1.2% solvent), which
is physically unreasonable. An alternative
explanation is that the space group is P41 or
P43 with merohedral twinning (with twin-
ning operator h, k, l = k, h, ÿl), giving rise to
the apparent higher symmetry of the
diffraction data. If one molecule of intact
protein is present in this lower symmetry
space group the value of VM is 2.5 AÊ
3 Daÿ1
(50.6% solvent). Other forms of crystal
twinning with lower symmetry monoclinic or
triclinic space groups, possibly containing
truncated protein, cannot be completely
discounted until the structure has been fully
re®ned.
3.2. Twinning tests
Analysis of the native data set for partial
twinning with CNS suggested a twinning
fraction of 0.46 and the Yeates twinning
server suggested a value of 0.47. The
cumulative intensity statistics for the acen-
tric re¯ections followed typical patterns for
non-twinned diffraction data. However, it is
recognized that pseudo-centring or strong
anisotropic diffraction, such as could occur
from a plate-like crystal or from a crystal
with one unit-cell edge much longer than the
others, can affect these statistics.
3.3. Preliminary phasing
Combining the selenomethionine MAD
data with the mercury-derivative data, the
positions of four out of ®ve possible sele-
nium positions and two mercury positions
were found with the program SOLVE
(Terwilliger & Berendzen, 1999), assuming
the space group to be P41 or P43. Whilst
both these space groups are consistent with
the crystal data and the positions found, only
P41 provided an electron-density map with
interpretable features.
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Table 1
Diffraction data statistics.
Values in parentheses are for the highest resolution shell.
Data set Native
SeMet
(in¯ection)
SeMet
(peak)
SeMet
(remote) KHgI3
Wavelength (AÊ ) 1.10 0.98067 0.98017 1.000 1.005
Resolution (AÊ ) 20±2.5 (2.57±2.5) 30±2.7 (2.83±2.7) 30±2.7 (2.83±2.7) 30±2.7 (2.83±2.7) 25±3.0 (3.09±3.0)
Unit-cell parameters (AÊ )
a = b 44.5 44.6 44.6 44.6 43.9
c 205.6 205.5 205.5 205.5 204.2
Total observations 33917 43493 43267 42829 42991
Space group P41/P43
Unique re¯ections 12439 10258 10237 10401 7409
Rmerge (%) 5.1 (10.4) 8.1 (25.7) 8.8 (27.0) 13.7 (49.9) 7.1(10.2)
Completeness (%) 90.8 (95.8) 93.2 (98.3) 93.1 (97.7) 93.5 (98.0) 95.6 (88.3)
I/(I) 16.4 (6.4) 7.0 (2.9) 6.9 (2.8) 5.3 (1.5) 12.4 (10.4)
Space group P41212/P43212
Unique re¯ections 7175 5984 5976 5966 4438
Rmerge (%) 5.6 (10.9) 8.5 (27.3) 9.2 (28.6) 14.5 (53.1) 7.7 (11.2)
Completeness (%) 91.8 (97.7) 93.5 (98.3) 93.5 (97.7) 93.9 (98.1) 97.8 (95.3)
I/(I) 20.3 (8.3) 6.8 (2.7) 6.6 (2.6) 5.0 (1.4) 15.2 (13.1)
Figure 3
SDS±polyacrylamide gel (15%) of denatured and
dissolved crystals of Mos1 transposase. Lane 1,
puri®ed Mos1 transposase; lane 2, crystallization drop
after removal of crystals; lane 3, dissolved crystals;
lane 4, molecular-weight markers (kDa).
